Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2000, p. 4260-4261, Vol. 38, No. 11
The Departments of
Pathology1 and
Medicine2 and The Edward
Mallinckrodt Department of Pediatrics,3
Washington University School of Medicine at St. Louis Children's
Hospital, St. Louis, Missouri
Received 15 June 2000/Returned for modification 20 July
2000/Accepted 23 August 2000
We evaluated the DiaSorin DNA enzyme immunoassay (DEIA) kit for
detection of enteroviral reverse transcription-PCR (RT-PCR) products
amplified from cerebrospinal fluid. By use of an optical density of
0.05 as the absorbance cutoff, 35% of 198 specimens were PCR positive,
whereas 16% were culture positive. DEIA was rapid and sensitive and
can help implement enterovirus RT-PCR in clinical laboratories.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evaluation of a Commercial DNA Enzyme Immunoassay
for Detection of Enterovirus Reverse Transcription-PCR Products
Amplified from Cerebrospinal Fluid Specimens
*
Corresponding author. Mailing address: Department of
Pediatrics, Washington University School of Medicine at St. Louis
Children's Hospital, One Children's Place, St. Louis, MO 63110. Phone: (314) 454-6079. Fax: (314) 454-2274. E-mail:
storch{at}kids.wustl.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»